Cellular Mechanisms Underlying Morphine Analgesic Tolerance and Hyperalgesia

Opioid-Induced Hyperalgesia

Volumn , Issue , 2016, Pages 9-20

  Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882584630     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420089004-5     Document Type: Chapter

References (58)

1. Brandt M, Fischer K, Moroder L, et al. Enkephalin evokes biochemical correlates of opiate tolerance and dependence in neuroblastoma x glioma hybrid cells. FEBS Lett 1976; 68(1): 38-40.
2. Collier HO, Francis DL. Morphine abstinence is associated with increased brain cyclic AMP. Nature 1975; 255(5504): 159-162.
3. Sharma SK, Klee WA, Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A 1975; 72(8): 3092-3096.
4. Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 2008; 154(2): 384-396.
5. Koch T, Hollt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 2008; 117(2): 199-206.
6. Marie N, Aguila B, Allouche S. Tracking the opioid receptors on the way of desensitization. Cell Signal 2006; 18(11): 1815-1833.
7. Martini L, Whistler JL. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 2007; 17(5): 556-564.
8. Wang ZJ, Wang LX. Phosphorylation: a molecular switch in opioid tolerance. Life Sci 2006; 79(18): 1681-1691.
9. Harada H, Ueda H, Katada T, et al. Phosphorylated mu-opioid receptor purified from rat brains lacks functional coupling with Gi1, a GTP-binding protein in reconstituted lipid vesicles. Neurosci Lett 1990; 113(1): 47-49.
10. Harada H, Ueda H, Wada Y, et al. Phosphorylation of mu-opioid receptors-a putative mechanism of selective uncoupling of receptor-Gi interaction, measured with low-Km GTPase and nucleotide-sensitive agonist binding. Neurosci Lett 1989; 100(1-3): 221-226.
11. Ueda H, Harada H, Nozaki M, et al. Reconstitution of rat brain mu opioid receptors with purified guanine nucleotide-binding regulatory proteins, Gi and Go. Proc Natl Acad Sci USA 1988; 85(18): 7013-7017.
12. Afify EA, Law PY, Riedl M, et al. Role of carboxyl terminus of mu-and delta-opioid receptor in agonist-induced down-regulation. Brain Res Mol Brain Res 1998; 54(1): 24-34.
13. Pak Y, O’Dowd BF, George SR. Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J Biol Chem 1997; 272(40): 24961-24965.
14. Belcheva MM, Szucs M, Wang D, et al. mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 2001; 276(36): 33847-33853.
15. Gucker S, Bidlack JM. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells. Mol Pharmacol 1992; 42(4): 656-665.
16. Koch T, Kroslak T, Mayer P, et al. Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J Neurochem 1997; 69(4): 1767-1770.
17. Pei G, Kieffer BL, Lefkowitz RJ, et al. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharmacol 1995; 48(2): 173-177.
18. Polakiewicz RD, Schieferl SM, Dorner LF, et al. A mitogen-activated protein kinase pathway is required for m-opioid receptor desensitization. J Biol Chem 1998; 273(20): 12402-12406.
19. Ueda H, Miyamae T, Hayashi C, et al. Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gi1-phospholipase C activation in Xenopus oocytes. J Neurosci 1995; 15(11): 7485-7499.
20. Ueda H, Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence-involvements of protein kinase C and anti-opioid glutamate-NMDA receptor system. Frontiers in Bioscience-regulation and function of opioid receptor genes. 2009; 14: 5260-5272.
21. Zhang J, Ferguson SS, Barak LS, et al. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 1998; 95(12): 7157-7162.
22. Ling GS, Paul D, Simantov R, et al. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci 1989; 45(18): 1627-1636.
23. Thompson AR, Ray JB. The importance of opioid tolerance: a therapeutic paradox. J Am Coll Surg 2003; 196(2): 321-324.
24. Yuan CS, Foss JF, O’Connor M, et al. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol 1998; 38(10): 931-935.
25. Gutstein HB, Akil H. Opioid analgesics. In: Bunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006: 547-590.
26. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251(4989): 85-87.
27. Ueda H, Inoue M. Peripheral morphine analgesia resistant to tolerance in chronic morphine-treated mice. Neurosci Lett 1999; 266(2): 105-108.
28. Ueda H, Inoue M, Matsumoto T. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J Neurosci 2001; 21(9): 2967-2973.
29. Manning BH, Morgan MJ, Franklin KB. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 1994; 63(1): 289-294.
30. Mao J, Sung B, Ji RR, et al. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002; 22(18): 8312-8323.
31. Trujillo KA. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berlin) 2000; 151 (2-3): 121-141.
32. Trujillo KA, Akil H. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol Biochem Behav 1991; 38(3): 673-675.
33. Bhargava HN. Enhancement of morphine actions in morphine-naive and morphinetolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. Gen Pharmacol 1997; 28(1): 61-64.
34. Bannerman DM, Rawlins JN, Good MA. The drugs don’t work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-Acontaining AMPA receptors to hippocampal-dependent memory. Psychopharmacology (Berlin) 2006; 188(4): 552-566.
35. Inoue M, Mishina M, Ueda H. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 2003; 23(16): 6529-6536.
36. Ravid T, Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol 2008; 9(9): 679-690.
37. Ko SW, Wu LJ, Shum F, et al. Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance. Mol Brain 2008; 1(1): 2.
38. Kozela E, Popik P. The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids 2002; 23(1-3): 163-168.
39. Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology (Berlin) 2003; 165(3): 245-251.
40. Liaw WJ, Zhang B, Tao F, et al. Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats. Neuroscience 2004; 123(1): 11-15.
41. Ammon S, Mayer P, Riechert U, et al. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res Mol Brain Res 2003; 112(1-2): 113-125.
42. 2þ-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J Neurosci 2004; 24(48): 10846-10857.
43. Befort K, Filliol D, Ghate A, et al. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala. Eur J Neurosci 2008; 27(11): 2973-2984.
44. Ferrer-Alcon M, La Harpe R, Guimon J, et al. Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology 2003; 28(5): 947-955.
45. Li BS, Sun MK, Zhang L, et al. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A 2001; 98(22), 12742-12747.
46. Zhang S, Edelmann L, Liu J, et al. Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors. J Neurosci 2008; 28(2): 415-424.
47. Small DL, Murray CL, Mealing GA, et al. Brain derived neurotrophic factor induction of N-methyl-D-aspartate receptor subunit NR2A expression in cultured rat cortical neurons. Neurosci Lett 1998; 252(3): 211-214.
48. Takayama N, Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci 2005; 25(2): 430-435.
49. Yonekubo S, Matsushita Y, Ueda H. Microglia activation is involved in the initiation of morphine analgesic tolerance. INRC, Charleston, SC, 2008: 46.
50. Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport 2009; 20(1): 63-68.
51. Akbarian S, Rios M, Liu RJ, et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci 2002; 22(10): 4153-4162.
52. Deng X, Yellaturu C, Cagen L, et al. Expression of the rat sterol regulatory elementbinding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1). J Biol Chem 2007; 282(24): 17517-17529.
53. Solomon SS, Majumdar G, Martinez-Hernandez A, et al. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci 2008; 83(9-10): 305-312.
54. Ozawa T, Nakagawa T, Shige K, et al. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxoneprecipitated withdrawal. Brain Res 2001; 905(1-2): 254-258.
55. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325(6104): 529-531.
56. Yoshikawa M, Shinomiya T, Takayasu N, et al. Long-term treatment with morphine increases the D-serine content in the rat brain by regulating the mRNA and protein expressions of serine racemase and D-amino acid oxidase. J Pharmacol Sci 2008; 107(3): 270-276.
57. Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001; 39(3): 281-286.
58. Liu W, Wang C-H, Cui, Y, et al. Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neurosci Lett 2006; 410(3): 174-177.